693 related articles for article (PubMed ID: 32852284)
1. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3.
Liao H; Zhang S; Qiao J
Aging (Albany NY); 2020 Aug; 12(20):20198-20211. PubMed ID: 32852284
[TBL] [Abstract][Full Text] [Related]
2. Suppression of lncRNA NLRP3 inhibits NLRP3-triggered inflammatory responses in early acute lung injury.
Luo D; Dai W; Feng X; Ding C; Shao Q; Xiao R; Zhao N; Peng W; Yang Y; Cui Y; Liu F; Qian K
Cell Death Dis; 2021 Oct; 12(10):898. PubMed ID: 34599154
[TBL] [Abstract][Full Text] [Related]
3. MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3.
Lin Y; Yang Y
Pathol Res Pract; 2019 Apr; 215(4):683-688. PubMed ID: 30600184
[TBL] [Abstract][Full Text] [Related]
4. Cyclic helix B peptide alleviates sepsis-induced acute lung injury by downregulating NLRP3 inflammasome activation in alveolar macrophages.
Zhang XP; Zhang WT; Qiu Y; Ju MJ; Yang C; Tu GW; Luo Z
Int Immunopharmacol; 2020 Nov; 88():106849. PubMed ID: 32795894
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of long non-coding RNA SNHG14 protects against acute lung injury induced by lipopolysaccharide through microRNA-34c-3p-dependent inhibition of WISP1.
Zhu J; Bai J; Wang S; Dong H
Respir Res; 2019 Oct; 20(1):233. PubMed ID: 31660971
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of pulmonary microvascular endothelial cells barrier dysfunction induced by LPS: The roles of ceramides and the Txnip/NLRP3 inflammasome.
Ouyang H; Wang Y; Wu J; Ji Y
Microvasc Res; 2023 May; 147():104491. PubMed ID: 36709858
[TBL] [Abstract][Full Text] [Related]
9. Sevoflurane anesthesia ameliorates LPS-induced acute lung injury (ALI) by modulating a novel LncRNA LINC00839/miR-223/NLRP3 axis.
Fu Z; Wu X; Zheng F; Zhang Y
BMC Pulm Med; 2022 Apr; 22(1):159. PubMed ID: 35473680
[TBL] [Abstract][Full Text] [Related]
10. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury by targeting NLRP3 via miR-381.
Zhang Y; Wang X; Liu Z; Yu L
J Biochem Mol Toxicol; 2018 Nov; 32(11):e22211. PubMed ID: 30102002
[TBL] [Abstract][Full Text] [Related]
13. lncRNA OIP5-AS1 knockdown or miR-223 overexpression can alleviate LPS-induced ALI/ARDS by interfering with miR-223/NLRP3-mediated pyroptosis.
Ji J; Ye W; Sun G
J Gene Med; 2022 Apr; 24(4):e3385. PubMed ID: 34346534
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-Meg3 promotes Nlrp3-mediated microglial inflammation by targeting miR-7a-5p.
Meng J; Ding T; Chen Y; Long T; Xu Q; Lian W; Liu W
Int Immunopharmacol; 2021 Jan; 90():107141. PubMed ID: 33189612
[TBL] [Abstract][Full Text] [Related]
15. Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway.
Li X; Qiu H; Gan J; Liu Z; Yang S; Yuan R; Gao H
J Ethnopharmacol; 2023 Oct; 314():116478. PubMed ID: 37121449
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF
J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
[TBL] [Abstract][Full Text] [Related]
17. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
18. NLRP3/ASC-mediated alveolar macrophage pyroptosis enhances HMGB1 secretion in acute lung injury induced by cardiopulmonary bypass.
Hou L; Yang Z; Wang Z; Zhang X; Zhao Y; Yang H; Zheng B; Tian W; Wang S; He Z; Wang X
Lab Invest; 2018 Aug; 98(8):1052-1064. PubMed ID: 29884910
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA MEG3 protects against sepsis-induced acute lung injury in mice through miR-93-5p-dependent inhibition of NF‑κB signaling pathway.
Gao H; Zhang X; Tang F; Chen L; Tian Z; Xiao D; Li X
Pathol Res Pract; 2022 Nov; 239():154142. PubMed ID: 36242967
[TBL] [Abstract][Full Text] [Related]
20. LncRNA XIST knockdown alleviates LPS-induced acute lung injury by inactivation of XIST/miR-132-3p/MAPK14 pathway : XIST promotes ALI via miR-132-3p/MAPK14 axis.
Li C; Liu JH; Su J; Lin WJ; Zhao JQ; Zhang ZH; Wu Q
Mol Cell Biochem; 2021 Dec; 476(12):4217-4229. PubMed ID: 34346000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
